Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04054986 · ClinicalTrials.gov registry record · Phase 1
Study of the Imaging Agent 18F-Var3 in Patients With Breast Cancer
A Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT04054986: Completed Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT04054986 is a Phase 1 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04054986, a Phase 1 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to measure the safety of the investigational imaging agent, 18F-Var3 and to determine if it is helpful in providing information about how tumor tissues behave.
Interventions
- OTHER Blood draw
- DIAGNOSTIC_TEST F-Var3 PET/CT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2019-08-09 |
| Est. Completion | 2020-09-18 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04054986
The ClinicalTrials.gov registry entry for NCT04054986 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blood draw is the first listed.
NCT04054986 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04054986 about?
NCT04054986 is a clinical study titled "Study of the Imaging Agent 18F-Var3 in Patients With Breast Cancer". The purpose of this study is to measure the safety of the investigational imaging agent, 18F-Var3 and to determine if it is helpful in providing information about how tumor tissues behave.
What is the current status of trial NCT04054986?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2019-08-09. Estimated completion is 2020-09-18.
What interventions are being tested in trial NCT04054986?
The interventions under investigation include: Blood draw (OTHER), F-Var3 PET/CT (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04054986?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.